Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genedata, a provider of in-silico solutions for pharmaceutical R&D and related life sciences, has announced high throughput screening collaboration with the Drug Discovery Center at the Genome Research Institute, University of Cincinnati.
Subscribe to our email newsletter
Genedata Screener, an open and scalable enterprise solution for high throughput screening and high content screening (HTS), will be completely integrated into the center’s HTS workflows.
The Drug Discovery Center is working on molecular probes for application in the pharmaceutical and biotech industries and needed a software solution to manage and analyze its small molecule screening campaigns. The Screener platform combines enterprise-wide assay data management with high-performance processing workflows and flexible analysis tools to rapidly analyze, integrate and manage all assay data, independent of instrumentation, technology, volume or location, said Genedata.
Othmar Pfannes, CEO of Genedata, said: “Genedata is excited to be working with the Drug Discovery Center to help forward their innovative research in screening of small molecules and cell-based assays. We are pleased to continue to provide tailored solutions for a broad range of applications including academic research projects.”